when: 24 June 2022 | venue: Cicada Innovations | cost: Free | address: 145/4 Cornwallis Street, Eveleigh NSW 2015 | website: https://www.cicadainnovations.com/ | tickets: https://www.eventbrite.com.au/e/what-if-biotechnology-could-cure-cancer-tickets-343820635777
published: 21 Jun 2022, 5 min read
This showcased event has concluded.
Expired
Forty percent of us will develop cancer in our lifetime. What if we found and treated cancer early? How many lives could it save? How much burden would it take off our healthcare system?
Join us for a special conversation between Sally-Ann Williams, CEO of Cicada Innovations, and Cyriac Roeding, Co-Founder and CEO of Earli, as we discuss how biotechnology could transform cancer detection and treatment in the future.
This in-person event will have Cyriac joining us virtually from California, and 3 successful biotech startups will be presenting their innovation in-person. At the end of the event, you will have a chance to network with our broader deep-tech and health tech community.
About Cyriac Roeding
Cyriac Roeding is an entrepreneur and investor who builds companies on the intersection of the physical, engineering and digital worlds. He has previously built three companies, and is an investor in more than 20 startups and venture funds including a16z, Bond, Founders Fund, Greylock, IVP, ZhenFund. He was named a World Economic Forum Tech Pioneer and a Fortune 40 Under 40 Mobilizer.
About Earli
US-based Biotech engineering company Earli is developing 'Synthetic Biopsy', a unique technology that forces cancer cells to reveal themselves. Originally from Stanford University, the radically new technique makes cancer produce synthetic biomarkers not normally expressed in the human body. The platform allows clinicians to exactly locate early cancers so they can be targeted and treated.
In 2021, Earli announced a $40 million in Series A funding led by Khosla Ventures, along with coinvestors including Andreessen Horowitz, Sands Capital, and top individuals Jim Breyer, Shlomo Ben-Haim, and Marc Benioff. They are currently conducting Phase 1 clinical trials of their technology at sites in Sydney, Melbourne and Adelaide.
This Cicada Innovations event is delivered in partnership with South Eveleigh.
The Visiting Entrepreneur Program is produced by the City of Sydney with partner organisations from the local startup ecosystem. The 2022 edition is kindly supported by Tech Central and the Greater Cities Commission.
Content from UpNext.com.au. Please don't scrape website.
Forty percent of us will develop cancer in our lifetime. What if we found and treated cancer early? How many lives could it save? How much burden would it take off our healthcare system?
Join us for a special conversation between Sally-Ann Williams, CEO of Cicada Innovations, and Cyriac Roeding, Co-Founder and CEO of Earli, as we discuss how biotechnology could transform cancer detection and treatment in the future.
This in-person event will have Cyriac joining us virtually from California, and 3 successful biotech startups will be presenting their innovation in-person. At the end of the event, you will have a chance to network with our broader deep-tech and health tech community.
About Cyriac Roeding
Cyriac Roeding is an entrepreneur and investor who builds companies on the intersection of the physical, engineering and digital worlds. He has previously built three companies, and is an investor in more than 20 startups and venture funds including a16z, Bond, Founders Fund, Greylock, IVP, ZhenFund. He was named a World Economic Forum Tech Pioneer and a Fortune 40 Under 40 Mobilizer.
About Earli
US-based Biotech engineering company Earli is developing 'Synthetic Biopsy', a unique technology that forces cancer cells to reveal themselves. Originally from Stanford University, the radically new technique makes cancer produce synthetic biomarkers not normally expressed in the human body. The platform allows clinicians to exactly locate early cancers so they can be targeted and treated.
In 2021, Earli announced a $40 million in Series A funding led by Khosla Ventures, along with coinvestors including Andreessen Horowitz, Sands Capital, and top individuals Jim Breyer, Shlomo Ben-Haim, and Marc Benioff. They are currently conducting Phase 1 clinical trials of their technology at sites in Sydney, Melbourne and Adelaide.
This Cicada Innovations event is delivered in partnership with South Eveleigh.
The Visiting Entrepreneur Program is produced by the City of Sydney with partner organisations from the local startup ecosystem. The 2022 edition is kindly supported by Tech Central and the Greater Cities Commission.
Go see What if biotechnology could cure cancer? 2022.
What if biotechnology could cure cancer? 2022 is on 24 June 2022. See start and end times below. Conveniently located in Eveleigh. Call 02 9209 4444 for details. Visit their website at https://www.cicadainnovations.com/.
Are we missing something? Help us improve this article. Reach out to us.
Event Details
Are you looking for 'Things To Do' ideas?
Upnext Team
We love helping people
See recent events discovered by Upnext Team
Expired
Adelaide Tiny Home Expo 2023
Discover Tiny Houses and why they are taking Australia by storm. Tiny houses on and off wheels, luxury Airbnb models, m...
Expired
Drag Bingo & Cocktail Fun! 2023
Celebrate a Sunday afternoon with Bingo with a difference...Drag Bingo.Join hosts Fifi and Princess Laya as they perform...
Expired
Have You Eaten? 2023
Have You Eaten? is an immersive art exhibition that invites you to consider your perfect picnic, favourite foods, and co...
Expired
Punk Protest Propaganda 2023
Discover The Political Art of Fahmi Reza, a captivating exhibition at Nexus Gallery.Fahmi Reza, a self-taught Malaysian ...
